Explore the top takeaways from the expert-led panel discussion, hosted by Bioiberica, to discover what lies ahead for the collagen market and how this impacts brands looking to succeed in the space.

Think you know collagen? Think again. Interest in collagen is at an all-time high, especially

in the joint health category – but many people remain mystified by the ingredient.

To find out why and dispel growing confusion in the marketplace, we’ve taken steps to uncover the reality of the current collagen landscape and debate the future of the sector. It started with The Collagen Symposium—a thought-provoking panel discussion that brought together key influencers to debunk the challenges, science and market opportunities in collagen. Building on this, we carried out The Collagen Industry Survey, interviewing 100+ health and nutrition professionals to reveal their perspectives of collagen and determine whether the uncertainty surrounding the ingredient is prevalent across the broader industry.  

This Collagen Symposium Hub is your gateway to access the latest industry insights designed to inspire, nurture and provide guidance for future developments in collagen and the joint health space. Start exploring now.  

Experts discuss how and why the term ‘collagen’ is being used to define different ingredients, some of which are not collagen at all – such as ‘vegan’ collagen.

Len Monheit describes what players across

the collagen industry can do to appeal to the 

collagen consumer; and create a long-term, sustainable marketplace.

Find out what Elizabeth Thundow has to say about the trends powering the collagen market and what the future holds for native type II collagen, specifically.

Effective at only 40 mg/day, compatible with multiple ingredients and suitable for various delivery formats. Could native type II collagen be the answer to the formulation conundrum?

Experts agree that native type II collagen holds significant potential in the joint health and 

mobility category. Daniel Martinez explains why. 

Ingrid Möller says that senior adults and sports enthusiasts are the two consumer groups that would benefit most from native type II collagen. Learn why.

Executive Director,

Collagen Stewardship

Alliance (moderator)

Pharmacist and Media Natural Health Expert

VP Consulting Nutrition, Frost & Sullivan

Head of Medical Affairs,  Apsen and Orthopaedic surgeon

Rheumatologist, Instituto Poal, UB, UIC

Head of R&D Human and Animal Health, Bioiberica

These statements have not been evaluated by the Food and Drug Administration or other competent food authorities. The product is not intended to diagnose, treat, cure, or prevent any disease. This information is only for business-to-business use and not meant to be addressed to final consumers. Therefore, Bioiberica assumes no liability for the statements that the producer of the final product may include in its own publicity to consumers.